Biotech Adam Feuerstein Brainstorm to seek FDA approval for ALS stem-cell treatment, despite agency objections
Health Andrew Joseph A treatment for monkeypox was approved under the FDA’s ‘Animal Rule.’ Here’s what that means
First Opinion Caitlin Rivers and Tom Inglesby FDA needs to fully review ACAM2000 before allowing its widespread use as a monkeypox vaccine
First Opinion Kristin E. Rojas The FDA needs to take another look at laser-based ‘vaginal rejuvenation’
First Opinion Elliott J. Millenson Containing Covid-19 requires rapid tests that are highly sensitive to infections. Why is the FDA asking for something different?
Pharmalot Ed Silverman FDA scolds Sun Pharma for allegedly backdating documents and fudging records for collecting drug samples
The Readout LOUD Damian Garde, Allison DeAngelis and Adam Feuerstein Listen: Private equity in autism care, a watershed FDA approval, and the future of ALS treatment
Biotech Adam Feuerstein Bluebird wins U.S. approval for a gene therapy to treat patients with a rare blood disorder
The Readout LOUD Damian Garde, Allison DeAngelis and Adam Feuerstein Listen: Helen Branswell on monkeypox, plus: an FDA controversy and fake Alzheimer’s data
Politics Matthew Perrone — Associated Press FDA weighs oversight changes after Juul, formula troubles
Health Nicholas Florko Court rules Juul can temporarily keep selling e-cigarettes while it prepares challenge to FDA ban
Politics Nicholas Florko The Biden administration wants to get tough on states’ abortion pill restrictions. It won’t be easy
Politics Nicholas Florko Despite fanfare, the FDA’s step toward lowering nicotine levels in cigarettes is a very early one
Politics Lev Facher Key Senate committee proposes a council to ensure FDA better coordinates on accelerated approvals
Politics Nicholas Florko The FDA says it’s in the dark about thousands of dietary supplement ingredients
D.C. Diagnosis Nicholas Florko As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms
Politics Nicholas Florko Congress moves toward reforming FDA accelerated approvals, but with pharma-friendly concessions
D.C. Diagnosis Nicholas Florko The FDA’s Rob Califf on importing drugs from Canada, on Aduhelm, and on opioids
Politics Nicholas Florko Medicare’s Brooks-LaSure expects restrictions on accelerated approval drugs, like those for Aduhelm, to be ‘very rare’
Pharma Ed Silverman The revolving door swings again as Lupin hires an FDA official who oversaw problems at a key plant
D.C. Diagnosis Nicholas Florko The FDA’s ban on menthol in cigarettes clears a major regulatory hurdle